Literature DB >> 26776093

Leptin Regulation of Immune Responses.

Caitlin Naylor1, William A Petri2.   

Abstract

Leptin is a regulatory hormone with multiple roles in the immune system. We favor the concept that leptin signaling 'licenses' various immune cells to engage in immune responses and/or to differentiate. Leptin is an inflammatory molecule that is capable of activating both adaptive and innate immunity. It can also 'enhance' immune functions, including inflammatory cytokine production in macrophages, granulocyte chemotaxis, and increased Th17 proliferation. Leptin can also 'inhibit' cells; CD4(+) T cells are inhibited from differentiating into regulatory T cells in the presence of elevated leptin, while NK cells can exhibit impaired cytotoxicity under the same circumstances. Consequently, understanding the effect of leptin signaling is important to appreciate various aspects of immune dysregulation observed in malnutrition, obesity, and autoimmunity.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  acquired immune system; innate; leptin regulation

Mesh:

Substances:

Year:  2016        PMID: 26776093     DOI: 10.1016/j.molmed.2015.12.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  80 in total

1.  Predictors of Subclinical Inflammatory Obesity: Plasma Levels of Leptin, Very Low-Density Lipoprotein Cholesterol and CD14 Expression of CD16+ Monocytes.

Authors:  Fernanda Leite; Ângela Leite; Ana Santos; Margarida Lima; Joselina Barbosa; Marco Cosentino; Laura Ribeiro
Journal:  Obes Facts       Date:  2017-07-22       Impact factor: 3.942

Review 2.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 3.  Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A review.

Authors:  Eric R Craig; Angelina I Londoño; Lyse A Norian; Rebecca C Arend
Journal:  Gynecol Oncol       Date:  2016-10-15       Impact factor: 5.482

Review 4.  Individuals at risk of seropositive rheumatoid arthritis: the evolving story.

Authors:  S Rantapää Dahlqvist; F Andrade
Journal:  J Intern Med       Date:  2019-10-21       Impact factor: 8.989

5.  The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysis.

Authors:  Yafei You; Chang Jiang; Kunwei Peng; Wenzhuo He; Lei Wang; Yanan Jin; Liangping Xia
Journal:  Cancer Immunol Immunother       Date:  2021-01-29       Impact factor: 6.968

Review 6.  Tissue Immunometabolism: Development, Physiology, and Pathobiology.

Authors:  Kevin Man; Vassily I Kutyavin; Ajay Chawla
Journal:  Cell Metab       Date:  2016-09-29       Impact factor: 27.287

Review 7.  Myeloid derived-suppressor cells: their role in cancer and obesity.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Curr Opin Immunol       Date:  2018-03-13       Impact factor: 7.486

8.  Decreased Long-Term Respiratory Infection Risk After Bariatric Surgery: a Comprehensive National Cohort Study.

Authors:  Jian-Han Chen; Yu-Feng Wei; Chung-Yen Chen; Yu-Chieh Su; Robert Shan Fon Tsai; Wei-Leng Chin; Ho-Shen Lee
Journal:  Obes Surg       Date:  2020-09-28       Impact factor: 4.129

9.  Bariatric surgery-induced weight loss reduces B cell activating cytokines and IgG immunoglobulins related to autoimmunity.

Authors:  Ricardo X Cuellar-Tamez; J Romeo Villarreal-Calderon; Nestor Rubio-Infante; Elena C Castillo; Manuel García-Garza; Leticia Elizondo-Montemayor; Gerardo García-Rivas
Journal:  Surg Endosc       Date:  2020-09-28       Impact factor: 4.584

Review 10.  Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes.

Authors:  William J Turbitt; Claire Buchta Rosean; K Scott Weber; Lyse A Norian
Journal:  Immunol Rev       Date:  2020-03-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.